We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Tekcapital Plc | LSE:TEK | London | Ordinary Share | GB00BKXGY798 | ORD �0.004 |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -0.16 | -2.03% | 7.74 | 1,035,443 | 16:35:22 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 7.70 | 8.00 | 7.85 | 7.85 | 7.85 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Computer Programming Service | USD 426k | USD 19.16M | USD 0.0883 | 0.89 | 17.14M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 16:35:22 | UT | 15,896 | 7.74 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 10/6/2025 | 07:00 | UK RNS | GenIP PLC Contract Win |
| 02/6/2025 | 07:02 | UK RNS | Tekcapital plc Notice of AGM |
| 02/6/2025 | 07:00 | UK RNS | MicroSalt PLC Final Results Year Ended 31 December Notice of AGM |
| 02/6/2025 | 07:00 | UK RNS | Tekcapital plc Fundraising of £1.25 Million |
| 29/5/2025 | 07:00 | UK RNS | Tekcapital plc Portfolio Company Update - Innovative Eyewear Inc |
| 23/5/2025 | 10:40 | ALNC |  Tekcapital swings to profit in 2024 on portfolio gains, AIM listings |
| 23/5/2025 | 07:00 | UK RNS | Tekcapital plc Final Results Year Ended 31 December 2024 |
| 16/5/2025 | 14:17 | ALNC | IN BRIEF: Tekcapital investee Guident wins WatchBot contract with BRiC |
| 16/5/2025 | 07:00 | UK RNS | Tekcapital plc Portfolio Company Update - Guident Corp |
| 12/5/2025 | 07:00 | UK RNS | Tekcapital plc Portfolio Company Update:Guident Corp Proposed IPO |
Tekcapital (TEK) Share Charts1 Year Tekcapital Chart |
|
1 Month Tekcapital Chart |
Intraday Tekcapital Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 16/6/2025 | 09:38 | TEK - TekCapital: Profit from University Intellectual Property | 5,850 |
| 26/4/2020 | 07:38 | Tekcapital at the UK Investor Show | 1 |
| 25/6/2019 | 07:40 | Tekcapital...healthy salt ! | 7 |
| 26/11/2007 | 15:48 | Teck-Cominco: strong mgmt, a spread of commodities | 2 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 15:35:22 | 7.74 | 15,896 | 1,230.35 | UT |
| 14:54:23 | 7.70 | 52,104 | 4,012.01 | O |
| 14:54:18 | 7.72 | 11,000 | 849.20 | O |
| 14:53:21 | 7.81 | 200,000 | 15,620.00 | O |
| 14:41:24 | 7.72 | 5,000 | 386.00 | O |
| Top Posts |
|---|
Posted at 17/6/2025 09:20 by Tekcapital Daily Update Tekcapital Plc is listed in the Computer Programming Service sector of the London Stock Exchange with ticker TEK. The last closing price for Tekcapital was 7.90p.Tekcapital currently has 216,902,333 shares in issue. The market capitalisation of Tekcapital is £17,026,833. Tekcapital has a price to earnings ratio (PE ratio) of 0.89. This morning TEK shares opened at 7.85p |
Posted at 11/6/2025 20:31 by buywell3 ---- Tekcapital (TEK) own 33.3 Million shares of Microsalt ( SALT) -----Both UK AIM listed shares , Tekcapital own 62.94% of Microsalt In addition Tekcapital holds approximately 2.6 million warrants in MicroSalt, exercisable for three years from the date of admission at 10% above the IPO price. In addition as of June 12th 2025 Tekcapital holds a convertible loan note in MicroSalt, valued at approximately $2 million. So if sales of Microsalt now proceed to accelerate as per the fial results June 1st 2025 of SALT , then IMO the valuation of Tekcapital should start to come into line with the Tekcapital shareholding in Microsalt There is a NEW Microsalt product called Microsalt Premium , which has not been included in the $2.5 million forecast for the coming financial year. · The launch of our MicroSalt Premium product line in January 2025 targeting the quick service and fast service restaurant (QSR/FSR) market with a focus on French fries, has been very well received and is already in final consideration for rollout with a top international brand Q3 of this year. · New sales staff were added to specifically address the opportunity for MicroSalt Premium within QSR/FSR market. · Completed R&D and final testing of our new patent pending product (Microsalt Premium) designed for the Quick Service Restaurants (QSR) and Fast Service Restaurants (FSR) sales channels. Premium not only provides entry into the foodservice segment including restaurants, hotels, hospitals, healthcare and single serve packaging, it provides a foot hold into the entire lower sodium efforts associated with the fast-food channel (Fries, bread, cheese, chicken, etc). In the US alone, over 4.5 billion pounds of French fries were consumed each year, with 2 billion orders from just the fast-food industry. The launch of our MicroSalt Premium product line in January targeting the quick service and fast service restaurant (QSR/FSR) market with a focus on French fries, has been very well received and is already in final consideration for rollout with a top international brand in Q3 of this year. This further demonstrates the expanding footprint of MicroSalt's functionality beyond just topical applications and into new markets such as cheese, peanut butter, chicken breading and coatings. -------------------- So IMO when the new patent pending for Microsalt Premium is granted one would imagine the Q3 rollout goes ahead with a vengeance , resulting in IMO a RNS containing revised guidance on increased revenues as a result. This IMO will bring another BIG name into the frame as a potential acquirer of the business OR Since their will be a separate IP for the new Microsalt Premium product --- which has been created SPECIFICALLY for the Fast Food Market. Could we see Microsalt being sold in two separate sales to two different companies ? dyor |
Posted at 07/6/2025 18:35 by clive323232 In investors chronicle it mentioned MicroSalt saying ' Bulk orders growing strongly , thus the high number of buy trades on Friday. Cud be future jam for TEK to increase the share price - but if and when, maybe not in the short termI noticed in the past that there can be a lot of buying g & the share price don't move - then suddenly the MM can't hold it down any more & bang it's off & it rises strongly. I do feel though for MicroSalt to change TEC share price sunstantially it is going to take quite some time after losing £5.8m. It's going to be a long road. |
Posted at 28/5/2025 07:59 by paleje ST has an updated positive viewAim-traded technology investment company plans to IPO its second largest holding on Nasdaq later this year This tech company has a catalyst for a re-rating Published on May 27, 2025 by Simon Thompson • NAV up 46 per cent to record $70.1mn (33c) • $20mn fair valuation gains on portfolio in 2024 • IPO of Guident could spark re-rating of Tekcapital Aim investment company Tekcapital (TEK:9.25p) reported its highest net asset value since inception, buoyed by $20mn (6.8p) of fair valuation gains on its concentrated portfolio. It was largely down to a $19.2mn gain on its 63 per cent stake in MicroSalt (SALT: 60.5p), a company that produces low-sodium salt. MicroSalt’s shares listed at 43p in an IPO in February 2024 and closed the year at 77p, valuing Tekcapital’s holding of 33mn shares at $36.9mn (12.6p). The company also holds $2.7mn (0.9p) of valuable convertible loan notes (CLNs) which are worth substantially more than their carrying valuation. MicroSalt whetted the appetite of investors by securing recurring bulk purchases of its full-flavour, low-sodium salt, for multiple product lines from one of the world’s largest food manufacturers. The company also anticipates additional purchase orders from the same customer for additional product lines in 2025, and significant higher B2B sales volumes, too. Read more from Investors’ Chronicle Can Diageo respond to health and tariff threats? The shares ‘wealth preservation’ trusts are buying Can our £2.5mn portfolio provide £60,000 a year?’ A catalyst for a re-rating Tekcapital’s second largest holding is a $18mn (6.1p) 100 per cent stake in Guident, a developer of remote monitoring and control software (RMCS) that improves the safety of autonomous vehicles and delivery robots. Tekcapital also holds $5mn (1.7p) of CLNs. Guident has constructed a state-of-the-art RMCS centre in Boca Raton, the largest office complex in Florida, incorporated the technology into AuVe autonomous shuttles and secured a strategic partnership with Star Robotics, a leading Spanish security robotics company. The partners plan to integrate Guident’s teleoperation solution into Star Robotics’ products to provide an autonomous security surveillance solution with a human-in-the-loop capability that can be rolled out across North America. In addition, Guident has invested in the fabrication and testing of regenerative shock absorbers for clients in the automotive industry and has a proof of concept agreement with a tier-1 tyre manufacturer for the patented technology. A planned IPO of Guident’s shares on Nasdaq this year could be a strong share price catalyst given that Tekcapital’s $23mn (7.8p) investment in the patented technology company has potential to be worth more than its own market capitalisation of £20mn. In addition, Tekcapital holds 11mn shares worth $4.1mn (1.4p) in GenIP (GNIP:24.5p) following last autumn’s IPO on London’s junior market. GenIP provides generative artificial intelligence (GenAI) analytic services to help companies, research institutions and venture funds assess and commercialise new discoveries. It combines expert human technical review with GenAI algorithms to provide insightful and verified services. True, Tekcapital’s listed portfolio is volatile, so much so that I estimate NAV has fallen from $70mn to $59mn since the year-end due to share price reversals in MicroSalt, Aim-traded respiratory medical device company Belluscura (BELL) and Innovative Eyewear (US: LUCY), the US operating subsidiary of Lucyd, the first company to deliver prescription glasses with Bluetooth technology. However, my spot NAV per share estimate of 20p is still more than double Tekcapital’s current share price. A successful IPO of Guident could materially reduce the discount to NAV. Buy. |
Posted at 23/5/2025 17:19 by lord loads of lolly cheshire - could you explain why any long term holder WOULD have a good word to say about Tek?Have you looked at its share chart any time recently? I hold purely because Cliff has destroyed so much of my original stake over time, it's no longer worth selling. I had hoped that when some of the holdings IPO'd they'd boost Tek's share price Sadly, time & again that hasn't happened. Which is why we're in this sorry state now. Never mind, I'm sure Buffet (Lunch) 2.0 & his various family cronies will soon explain what the XXXX they mean by "A penny saved is two pence clear", given how many pennies they've shaved off Tek's share price over the years. And when Clifford repeats Warren Buffett's mantra: "Value creation is not dependent on diversification but rather on carefully investing for the long-term in the right assets", I presume he's excluding Tek, given how it's performed. |
Posted at 24/3/2025 10:08 by ivyhedge It is more to do with the general malaise within the market in the UK than anything else. TEK has some very good holdings worth much more than the share price shows.Look at SALT announcement this morning, in the right conditions TEK share price would have ticked up nicely. The UK government has tried its best to wreck the economy hence the continuous slide in share prices. Trump is doing the same over the pond. The value in TEK shares is many times greater than its present level but people are not ready to risk thier money when the world is hell bent on destruction and war (trade and otherwise). All I will say is that when I have spare money I buy a few more of these as well as other lowly rated shares. |
Posted at 06/2/2025 07:50 by cheshire The performance of Tekcapital has disappointed many investors over recent years as the share price has risen and then dropped to the current low levels. What will change this situation is a material monetisation which allows Tekcapital to issue those much-awaited Special Dividends. We now have an exceptionally good chance of experiencing one or even two such events this year. On the first Special Dividend the Share Price will correct as the Tekcapital model will have been proven. See the presentation below. https://www.tekcapit |
Posted at 05/11/2024 12:23 by 888icb When Simon Thompson valued TEK on 31st October:“ spot net asset value (NAV) is around $65.2mn (25.3p), or almost three times the company’s current share price. The 32 per cent rally in Tekcapital’s share price since I highlighted the valuation anomaly (‘IPOs set to drive a rerating of an unloved investment company’, 25 September 2024) has much further to run to narrow the 63 per cent share price discount to NAV. Buy.” When he did that valuation SALT was 77p whereas today it’s 92p so it’s a few million dollars light. Its also worth remembering what he said about Guident, which unlike the other investments has not yet been listed: “ Furthermore, there is scope to unlock the value in Tekcapital’s largest investment, an $18.1mn (6.8p) equity holding in Guident, a developer of remote monitoring and control software (RMCS) that improves the safety of autonomous vehicles and delivery robots. Tekcapital holds $4.3mn (1.6p) of CLNs in the company, too. The directors are in the process of seeking a private investment round ahead of a likely IPO, another share price catalyst and one that’s not in the price.” I think Guident is becoming a leading player in an industry that has massive growth potential and will turn out to be the jewel in TEK’s crown. |
Posted at 03/10/2024 19:07 by 888icb IC article valuation tableTekcapital's portfolio fair value estimate Portfolio company Carrying value 30 June 2024 Estimated carrying value on 25 September 2024 Value per share Guident $18.1mn $18.1mn 6.8p Innovative Eyewear $2.6mn $2.6mn 1.0p MicroSalt $38.9mn $22.8mn 8.6p Belluscura $2.2mn $1.4mn 0.5p GenIP $0.2mn $0.2mn 0.1p Smart Food Tek $0.0mn $0.0mn 0.0p Guident convertible loan notes $4.3mn $4.3mn 1.6p TekEurope $1.2mn $1.2mn 0.5p MicroSalt convertible loan notes $2.0mn $2.0mn 0.8p Portfolio fair value $69.5mn $52.6mn 19.8p Cash $0.3mn $0.3mn 0.1p Total NAV $69.8mn $52.9mn 19.9p It doesn’t copy toowell but you should be able to work it out such that although the value of the portfolio has fallen from $69.8 million in June to $52.9 million on 24th September due to the fall in SALTs share price the NAV per share is 19.8p compared to todays closing price of 6.1p. The final part of the article: “ Shareholders in Tekcapital should note that portfolio company GenIP (GNIP:39p) raised £1.75mn in an IPO on London’s junior market on 2 October 2024. The company provides generative artificial intelligence (GenAI) analytic services to help companies, research institutions and venture funds assess and commercialise new discoveries. GenIP combines expert human technical review with GenAI algorithms to provide insightful and verified services. The holding in GenIP had a £0.2mn carrying value in Tekcapital’s interim accounts, but the company’s retained 62.8 per cent stake post IPO is worth £4.3mn (2.15p), which boosts Tekcapital’s spot NAV to 22p a share. On this basis, the investment company’s share price is trading two-thirds below book value. Poor sentiment towards micro-cap companies and Aim companies explain part of the discount, as highlighted by the 29 per cent reversal in the FTSE All-Share Total Return index since I included Tekcapital’s shares in my 2022 Bargain Shares Portfolio. However, the level of risk aversion is extreme and completely ignores the multiple short-term catalysts that could narrow the share price discount to NAV. Recovery BUY” |
Posted at 14/9/2024 17:30 by jaknife 888ICB,"Don’t forget Guidant which has great technology in markets that have massive growth potential. Guidant could well be the jewel in the crown that transforms TEK’s cash situation when it IPO’s." Guidant is a pile of poo. The only reason that you might think otherwise is: A. TEK Capital have done a skanky revaluation of the underlying assets. In 2018 TEK invested a mere $23.5k into Guident Limited, they then did a skanky deal to revalue Guident such that, at year-end, they could claim to shareholders that Guident was worth $8.5m! Since then TEK have performed other transactions such that they can revalue the shares and claim that they are worth a large number. B. TEK Capital have made wildly promotional claims about Guident. This follows a pattern of behaviour that TEK Capital have displayed over numerous years. First it was Lucyd that was launched to a fanfayre that then flopped, then it was Belluscura where a culture of making wildly optimistic sales was created - it too has flopped. Number three was Microsalt where , yet again, expectations of greatness have been created and yet the reality is proving to be much plainer. Microsalt's interims results are due later this month and they will show trivial revenues, material losses and a super weak balance sheet. The share price since IPO has begun the same downward trend that has occurred with both Lucyd and Belluscura! Anyone who believes that Guident is a hugely successful business, after seeing TEK Capital's track record of hopelessly wild over-promotional claims for its previous three investments, is nought but a fool. The reality with Guident is that it's a pre-revenue business that's burning cash whilst trying to compete with Tech giants who have significantly deeper pockets. It will require material amounts of additional investment before it's even at a revenue generating stage. And the reality with TEK Capital is that its product is dreams - it sells dreams to its retail shareholder base and they lap them up every time, over-paying for shares of the poor companies that it floats. JakNife |
Posted at 15/5/2024 16:16 by davebowler The Oakbloke saysCan Lucyd Armor save us? Dear reader, In FY23 Lucy results I wrote Nasdaq-listed LUCY needs 80% Quarter to Quarter growth in revenue and improvement in margin. Net revenue for the quarter ended March 31, 2024 was $383,471, which was an increase of 165% from the quarter ended March 31, 2023. That sounds impressive. Various share news services are proudly broadcasting this. LUCY shares were up 22% at one point today. This year-over-year increase was primarily attributable to significant volume growth in the e-commerce channel, driven by the Company's strategic advertising and marketing initiatives during the latter portion of 2023 and through the current quarter, combined with recent new product launches (including the Lyte XL and Nautica® Powered by Lucyd collections). Wonderful. But not so fast. Quarter to Quarter the picture is far less rosy. $559,759 revenue falls to $383,471 vs my own estimates where an 80% growth to $1m in Q1 would put this on a path to profitability. We are miles away from any such outcome. On a more positive note, Quarter to Quarter gross profitability increases $187k (to a positive but paltry $6,951 gross profit). The commentary points to discounting due to competitive pressures but analysis shows the prescription lenses generated that $7k profit while non-prescription actually lost money. No one else sells prescription smart glasses so what discount? It’s not at all clear. Sales falling from 34% to just 4% of sales via reseller partners suggests the strategy of “small independent retailers” has comprehensively failed. LUCY speak to switching to larger retailers but say this will take time. A very disappointing development. The Blueshift Premium lenses whilst providing a form of differentiation also appears to be an explanation of the high cost of sales of non prescription glasses. Why add this feature and sell it at a loss? It is frustrating to see this has detracted from progress towards break even. The lack of commercial control is disappointing. LUCY management speak to realising some economies of scale in the cost of frames and in the area of shipping and logistics. However they (confusingly) blame the growth in prescription costs impacting gross margin too. If you compare revenue and cost of sales for prescription and non-prescription then this is completely contradictory. LUCY say they are working with the current prescription lens provider to explore opportunities to reduce costs and we are also actively in discussions with alternative prescription lens suppliers who may help further lower lens fulfillment costs. It’s not clear why the costs have grown so much and why was there no price agreement in place? It sounds like a lack of commercial control - allowing the supplier to increase prices - have LUCY been taken for a ride? The long-term goal of shifting the sales mix over time more towards the wholesale channel, which carries higher margins, LUCY claim as such sales to our third-party retail store partners do not include the cost of prescription lenses. Wholesale should never carry higher margins than selling retail (direct) to the end user. Another contradiction to contend with. Future Outlook Three new product lines - Eddie Bauer® Reebok® and the Lucyd Armor smart safety glasses line (Previously Lion) are due to launch in 2024. Meanwhile plans to launch new features for the Lucyd app in 2024, including a paid "Pro" version of the app, could provide another potential incremental revenue stream for the Company too. Harrison Gross, CEO of Innovative Eyewear Inc., commented, "After several years of rigorous R&D and brand development, I believe we are very well-positioned to capitalize on blooming consumer interest in smart eyewear. Recently, we have seen powerful incumbents such as Apple and Meta bringing renewed interest to smart glasses. We continue to expect that smart eyewear will be a key component of the generative AI revolution, due to their transparent interfaces and ergonomic form factors perfectly suited for voice-based interaction." Tekcapital owns 5.2 million shares in Innovative Eyewear which is ~40% of the total issued share capital of LUCY. LUCY’s share price has dropped $0.29 to $0.20 since my Q4 update. Ouch. At today’s market price of $0.20 that ownership is worth $1m/£0.8m or 0.4p/TEK share (TEK is £17.2m market cap total at today’s 9p ask). Because TEK has a controlling interest there’s a 15% mark up on the NAV so 0.46p/TEK share. Conclusion 1Q24 is a disappointment. Those Investor publications who’ve regurgitated the 165% Revenue Increase year on year “news” have missed the point. You might as well boast that Smart Eyewear sales have increased since the Victorian times also. The hope now is that Q2 addresses not only the cost of sale challenge but also the sales growth challenge simultaneously. As well as progress the launch of three new brands including one for a completely new type of glasses to a completely new type of customer (B2B Industrial) whereas 100% of marketing has been to B2C fashion and tech savvy consumers. The Armor glasses aren’t a bad idea but are also a huge distraction in a new direction. $1.02m has been raised post period; but this provides about 2 months additional runway based on current cash burn. I have finally run out of patience with this holding and am writing it off to zero in my analysis, pending a tremendous turn around in Q2 which I am now sceptical can and will arrive. For UK investors who hold LUCY as part of TEK, writing off 0.4p per TEK share is actually less than increases at other TEK holdings, for example SALT has increased by 1.1p per TEK share (i.e. 95p/97p bid ask today) in the past 2 weeks. A NAV of 23.6p excluding LUCY versus a 9p ask is a 62% discount where 154% of the TEK price is covered by the value of LISTED holdings (or 188% if we still include LUCY). Thanks for reading The Oak Bloke’s Substack! Subscribe for free to receive new posts and support my work. Pledge your support Regards The Oak Bloke Disclaimers: This is not advice Micro cap and Nano cap holdings might have a higher risk and higher volatility than companies that are traditionally defined as "blue chip". The Oak Bloke’s Substack is free today. But if you enjoyed this post, you can tell The Oak Bloke’s Substack that their writing is valuable by pledging a future subscription. You won't be charged, unless they enable payments, and you decide to continue with a subscription. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
